MedPath

Coagulation Profile of Patients Undergoing CRS(Cytoreductive Surgery) and Hyperthermic Intraperitoneal Chemotherapy

Completed
Conditions
Haematological Abnormality
Interventions
Other: thromboelastography
Registration Number
NCT03137745
Lead Sponsor
Rajiv Gandhi Cancer Institute & Research Center, India
Brief Summary

To study the changes in coagulation profile in patients undergoing cytoreductive surgery and Hyperthermic intraperitoneal chemotherapy. The objective of the study is to determine the utility of thromboelastography in comparison to standard coagulation tests in assessing the coagulopathy in patients undergoing CRS with HIPEC.

Detailed Description

This is a prospective observational study conducted in 60 patients undergoing CRS with HIPEC in RGCIRC from march 2015- march2016 after taking permission from the institutional review board and informed written consent from the patients.

Arterial blood samples were collected before and after HIPEC and on first and second postoperative day for PT,APTT INR,TEG and ABG. Statistical analysis was done using chi square test and unpaired t- test for categorical and continuous variables. Pearson's correlation coefficient was calculated for analysing the correlation between the variables .P - value \<0.05 was considered statistically significant.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • ASA 1&2
  • Undergoing CRS with HIPEC
Exclusion Criteria
  • extremities of age
  • patients with coagulopathy
  • patients on anticoagulant preoperatively sever organ dysfunctions

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
all patients undergoing CRS with HIPECthromboelastographythromboelastography was done in 60 patients undergoing CRS with HIPEC in RGCI FROM MARCH2015- MARCH 2016
Primary Outcome Measures
NameTimeMethod
comparison of thromboelastograph values with standard coagulation tests1.5 hours after HIPEC

arterial samples were taken for thromboelastography and prothrombin time(seconds), fibrinogen( mg) and patial thromboplastin time( seconds)

Secondary Outcome Measures
NameTimeMethod
comparison of various thromboelastograph values with standard coagulation tests24hours and 48 hours after HIPEC

arterial samples were taken for thromboelastography and prothrombin time(seconds), fibrinogen( mg) and partial thromboplastin time(seconds)

© Copyright 2025. All Rights Reserved by MedPath